Innovent Biologics, Inc. (HKG:1801)
Hong Kong
· Delayed Price · Currency is HKD 50.70
+1.30 (2.63%)
May 13, 2025, 1:45 PM HKT
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of 81.49 billion as of May 12, 2025. Its market cap has increased by 40.08% in one year.
Market Cap
81.49B
Enterprise Value
76.11B
Revenue
10.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
50.70
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 18.54B to 81.49B, an increase of 339.54%. That is a compound annual growth rate of 25.43%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 194.78B |
| Hansoh Pharmaceutical Group Company | 140.92B |
| JD Health International | 117.99B |
| WuXi Biologics | 93.82B |
| Alibaba Health Information Technology | 80.09B |
| Akeso | 75.71B |
| Sichuan Kelun-Biotech Biopharmaceutical | 71.46B |
| Sino Biopharmaceutical | 69.96B |